Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Silencer Select siRNAs

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 2 October 1998:
Vol. 282. no. 5386, p. 27
DOI: 10.1126/science.282.5386.27
Prev | Table of Contents | Next

News of the Week

GENETIC DISEASES:
RAC Confronts in Utero Gene Therapy Proposals

Jennifer Couzin

A National Institutes of Health advisory committee last week began what could be a long debate over whether to permit the next step in gene therapy: correcting genetic defects in a fetus before birth. Researchers say they may be ready to attempt such an experiment in 2 or 3 years, but fetal gene therapy carries potential new risks and ethical implications--including the possibility that transplanted genes could end up in sperm or egg (germ) cells and be passed on to future generations.

Read the Full Text

ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)